NOVNQ vs. NOVN, STAB, SCPS, VRAYQ, AHPI, GNCA, HTGMQ, IGNY, ONCSQ, and CNTX
Should you be buying NVN Liquidation stock or one of its competitors? The main competitors of NVN Liquidation include Novan (NOVN), Statera Biopharma (STAB), Scopus BioPharma (SCPS), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Genocea Biosciences (GNCA), HTG Molecular Diagnostics (HTGMQ), Ignyte Acquisition (IGNY), OncoSec Medical (ONCSQ), and Context Therapeutics (CNTX). These companies are all part of the "medical" sector.
Novan (NASDAQ:NOVN) and NVN Liquidation (NASDAQ:NOVNQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership, community ranking and analyst recommendations.
Novan received 239 more outperform votes than NVN Liquidation when rated by MarketBeat users.
14.5% of Novan shares are owned by institutional investors. 1.3% of Novan shares are owned by company insiders. Comparatively, 1.3% of NVN Liquidation shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
NVN Liquidation has a net margin of 0.00% compared to NVN Liquidation's net margin of -128.61%. Novan's return on equity of 0.00% beat NVN Liquidation's return on equity.
In the previous week, NVN Liquidation's average media sentiment score of 0.00 equaled Novan'saverage media sentiment score.
Novan has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500. Comparatively, NVN Liquidation has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500.
Summary
NVN Liquidation beats Novan on 5 of the 8 factors compared between the two stocks.
Get NVN Liquidation News Delivered to You Automatically
Sign up to receive the latest news and ratings for NOVNQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NOVNQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NOVNQ vs. The Competition
NVN Liquidation Competitors List
Related Companies and Tools
